Feb 2022 $53 M Issued in a merger or acquisition $50 to $250 million 38
Modernizing Medicine Inc.: Private sale, Feb 2022 × Investors in this round 38 investors had bought by the notice of Feb 22, 2022: 38 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $53 M of $53 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Cane · Executive Officer, Director Joseph Harpaz · Executive Officer Mark Fleisher · Executive Officer Michael Sherling · Executive Officer, Director Michelle Scheer · Executive Officer Amr Kronfol · Director Andrew Park · Director Barry Mosheim · Director Gary Steele · Director Gina Loften · Director Jean Bua · Director Phillip Pead · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Fleisher, Senior Executive Vice President and General Counsel. Source: SEC Form D, newest notice filed Feb 22, 2022. Read the notice at the SEC .
equity SEC May 2017 $206 M No. 5 $50 to $250 million 6
Modernizing Medicine Inc.: Raise no. 5, May 2017 × Investors in this round 6 investors had bought by the notice of May 22, 2017: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $206 M of $231 M offered; $25 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Cane · Executive Officer, Director Karen O'Byrne · Executive Officer Mark Fleisher · Executive Officer Michael Sherling · Executive Officer, Director Rick Von Pusch · Executive Officer Amr Kronfol · Director Barry Mosheim · Director Fred Hassan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Fleisher, Senior Executive Vice President and General Counsel. Source: SEC Form D, newest notice filed May 22, 2017. Read the notice at the SEC .
equity, options SEC Sep 2015 $38 M Issued in a merger or acquisition $10 to $50 million 7
Modernizing Medicine Inc.: Private sale, Sep 2015 × Investors in this round 7 investors had bought by the notice of Sep 15, 2015: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $38 M of $38 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Cane · Executive Officer, Director Karen O'Byrne · Executive Officer Mark Fleisher · Executive Officer Michael Sherling · Executive Officer, Director Barry Mosheim · Director Mark deLaar · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Fleisher, Senior Executive Vice President and General Counsel. Source: SEC Form D, newest notice filed Sep 15, 2015. Read the notice at the SEC .
equity, options SEC Nov 2014 $16 M No. 4 $10 to $50 million 60
Modernizing Medicine Inc.: Raise no. 4, Nov 2014 × Investors in this round 60 investors had bought by the notice of Nov 12, 2014: 60 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $16 M of $20 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brad Rennick · Executive Officer Daniel Cane · Executive Officer, Director Karen O'Byrne · Executive Officer Mark Fleisher · Executive Officer Michael Sherling · Executive Officer, Director Patric Edmondson · Executive Officer Barry Mosheim · Director Mark deLaar · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Fleisher, Senior Executive Vice President and General Counsel. Source: SEC Form D, newest notice filed Nov 12, 2014. Read the notice at the SEC .
equity, options SEC Aug 2013 $14 M No. 3 $10 to $50 million 4
Modernizing Medicine Inc.: Raise no. 3, Aug 2013 × Investors in this round 4 investors had bought by the notice of Aug 20, 2013: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $14 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Cane · Executive Officer, Director Karen O'Byrne · Executive Officer Mark Fleisher · Executive Officer Michael Sherling · Executive Officer, Director Barry Mosheim · Director Mark deLaar · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Fleisher, Senior Executive Vice President and General Counsel. Source: SEC Form D, newest notice filed Aug 20, 2013. Read the notice at the SEC .
equity, options SEC Jul 2012 $7 M No. 2 $2 to $10 million 67
Modernizing Medicine Inc.: Raise no. 2, Jul 2012 × Investors in this round 67 investors had bought by the notice of Jul 17, 2012: 67 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $8 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Cane · Executive Officer, Director James Brooks · Executive Officer Karen O'Byrne · Executive Officer Mark Fleisher · Executive Officer Michael Sherling · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Fleisher, Vice President and General Counsel. Source: SEC Form D, newest notice filed Jul 17, 2012. Read the notice at the SEC .
equity, options SEC Feb 2011 $7 M No. 1 $2 to $10 million 47
Modernizing Medicine Inc.: Raise no. 1, Feb 2011 × Investors in this round 47 investors had bought by the notice of Mar 1, 2011: 47 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Daniel Cane · Director, Executive Officer Michael Sherling, M.D. · Director, Executive Officer Robert Nagro · Executive Officer Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Daniel Cane, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 1, 2011. Read the notice at the SEC .
equity, debt, options SEC